Answers are grounded in this paper and cite their sources.
This research reveals how nanoparticles trigger immune reactions in the liver and spleen, suggesting implications for drug delivery systems.
Background Systemically administered nanoparticles (NPs) designed for biomedical applications are retained in liver and spleen where they become rapidly phagocyted by tissue macrophages leading to inflammation.
No takes yet. Share an insight, caveat, or question.
Brodin et al. (2025) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: